Effect of an Individual Counseling Session on Physical Activity Level of Individuals With COPD

July 25, 2023 updated by: Tiago Miguel dos Santos Pastilha, Polytechnic Institute of Porto

Effect of an Individual Counseling Session on Physical Activity Level of Individuals With Chronic Obstructive Pulmonary Disease (COPD) - Randomized Controlled Study (RCT)

The goal of this randomized clinical trial is to study the effect of an individual counseling session on the level of physical activity and motivation to practice physical exercise in individuals with COPD. The main question[s] it aims to answer are:

• Does a counseling session improve the level of physical activity and motivation to practice physical exercise in individuals with COPD?

Participants will perform a respiratory rehabilitation program (Control Group, CG) and a respiratory rehabilitation program and the counseling session (Experimental Group, EG).

Researchers will compare EG to CG to see if there is any difference in physical activity level and motivation to exercise between groups.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Coimbra
      • Figueira Da Foz, Coimbra, Portugal, 3094-001
        • Recruiting
        • Hospital Distrital da Figueira da Foz, EPE
        • Contact:
        • Sub-Investigator:
          • Rita Santos, MSc
        • Sub-Investigator:
          • Vitória Martins, MSc
        • Sub-Investigator:
          • Viviana Sebastião
        • Sub-Investigator:
          • Ana Alexandrino, PhD
        • Sub-Investigator:
          • Rui Macedo, PhD
        • Sub-Investigator:
          • Susana Vale, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Portuguese nationality;
  • Medical diagnosis of COPD according to Global Initiative for Chronic Obstructive Lung Disease (GOLD 2022);
  • Aged over 40 years.

Exclusion Criteria:

  • underwent recent orthopedic surgeries (<3 months);
  • Pregnant;
  • Terminal illness diagnosis (life expectancy of less than 6 months);
  • High cardiovascular risk classification for the practice of physical activity according to American College of Sports Medicine (ACSM 2018).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Physical Activity Counseling + Pulmonary Rehabilitation
The counseling session on physical activity was carried out individually, six weeks after starting the respiratory rehabilitation program, with an average duration of 30 minutes, based on the guidelines of the Living Well with COPD program. The main objective of the session was: to help the participant and family members to increase physical activity levels and their integration in the long term and as secondary objectives; reinforce the importance and benefits of physical activity in the management of the health condition/symptoms; plan daily/weekly moments of physical activity; define daily goals (physical activity time/sitting time) attainable for each participant; integrate family members/companions into the user's physical activity plan; clarify doubts of the user/relative about the theme.
The counseling session on physical activity was carried out individually, six weeks after starting the respiratory rehabilitation program, with an average duration of 30 minutes, based on the guidelines of the Living Well with COPD program. The main objective of the session was: to help the participant and family members to increase physical activity levels and their integration in the long term and as secondary objectives; reinforce the importance and benefits of physical activity in the management of the health condition/symptoms; plan daily/weekly moments of physical activity; define daily goals (physical activity time/sitting time) attainable for each participant; integrate family members/companions into the user's physical activity plan; clarify doubts of the user/relative about the theme.
The program comprises a hospital group exercise program, twice a week, on alternate days, for 1h30 to 2h, each session.
Active Comparator: Pulmonary Rehabilitation
The program comprises a hospital group exercise program, twice a week, on alternate days, for 1h30 to 2h, each session, which included: monitoring of vital signs, peripheral oxygen saturation (SpO2), subjective perception of exertion (RPE), dyspnea and body mass; warm-up phase (10min), with ventilatory control and low-intensity upper and lower limb exercises; continuous aerobic training phase, performed on a treadmill, static cycle ergometer and/or arm ergometer (30-45min), at 60-80% of the maximum Cardiopulmonary Exercise Test load; strength training phase, with free weights, machines (10-20min), at 50-80% of the Maximum Repetition (RM), (8-12 repetitions), 1-2 sets, 8-10 exercises ( upper limbs, trunk and lower limbs); cooling phase (5-10min), with 5 to 8 relaxation, stretching and ventilatory control exercises. The progression of training loads is carried out according to RPE and dyspnea, safeguarding SpO2 values above 88-90% and Heart Rate below the maximum defined for training.
The program comprises a hospital group exercise program, twice a week, on alternate days, for 1h30 to 2h, each session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average Daily Steps
Time Frame: 7 days
quantitative variable met through the daily average of the steps, using accelerometer data.
7 days
Light Physical Activity
Time Frame: 7 days
quantitative variable evaluated with the accelerometer, measured in minutes.
7 days
Moderate Physical Activity
Time Frame: 7 days
quantitative variable evaluated with the accelerometer, measured in minutes.
7 days
Vigorous Physical Activity
Time Frame: 7 days
quantitative variable evaluated with the accelerometer, measured in minutes.
7 days
Sedentary Activity
Time Frame: 7 days
quantitative variable evaluated with the accelerometer, measured in minutes.
7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tiago Pastilha, PT, Escola Superior de Saúde
  • Study Director: Ana Alexandrino, PhD, Escola Superior de Saúde
  • Study Director: Susana Vale, PhD, Escola Superior de Educação
  • Study Director: Rui Macedo, PhD, Escola Superior de Saúde

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2022

Primary Completion (Estimated)

September 30, 2023

Study Completion (Estimated)

November 30, 2023

Study Registration Dates

First Submitted

July 16, 2023

First Submitted That Met QC Criteria

July 16, 2023

First Posted (Actual)

July 27, 2023

Study Record Updates

Last Update Posted (Actual)

July 27, 2023

Last Update Submitted That Met QC Criteria

July 25, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 16.OBS.2020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COPD

Clinical Trials on Physical Activity Counseling session

3
Subscribe